Growth & profitability
- Revenue has declined 2.2% per year over the past 5 years.
- Operating margin has expanded, at 1.0% in the latest year.
Financial health
- Operating income covered interest expense 0.1× in the latest year.
NHP Financials National Healthcare Properties, Inc.
13 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $342M | -$58M | 36.0% | 1.0% | — | — | $58M |
| 2024 | $354M | -$190M | 37.4% | -34.9% | — | — | $22M |
| 2023 | $346M | -$72M | 37.0% | -1.4% | — | — | $46M |
| 2022 | $336M | -$80M | 36.4% | -9.4% | — | — | $54M |
| 2021 | $329M | -$85M | 37.5% | -11.4% | — | — | $60M |
| 2020 | $382M | -$76M | 36.2% | -5.2% | — | — | $72M |
| 2019 | $375M | -$88M | 37.5% | -8.5% | $31M | — | $96M |
| 2018 | $362M | -$53M | 39.0% | -0.9% | $41M | — | $77M |
| 2017 | $311M | -$43M | 40.1% | -3.9% | $56M | — | $94M |
| 2016 | $303M | -$21M | 43.1% | -1.1% | $71M | — | $29M |
| 2015 | $247M | -$42M | 49.3% | -14.4% | $62M | — | $24M |
| 2014 | $58M | -$38M | 54.3% | -58.7% | -$7M | — | $183M |
| 2013 | $2M | -$221000 | 93.3% | -11.9% | -$764000 | — | $112M |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $86M | -$4M | 38.7% | 11.7% | — | — | $53M |
| Dec '25 | $84M | -$23M | 37.2% | -7.8% | — | — | $58M |
| Sep '25 | $86M | -$13M | 37.4% | 2.8% | — | — | $47M |
| Jun '25 | $85M | -$21M | 36.9% | -6.5% | — | — | $47M |
| Mar '25 | $86M | -$2M | 33.1% | 15.1% | — | — | $71M |
| Dec '24 | $88M | -$17M | 37.4% | -1.2% | — | — | $22M |
| Sep '24 | $89M | -$41M | 36.6% | -23.5% | — | — | $33M |
| Jun '24 | $89M | -$117M | 38.1% | -113.1% | — | — | $29M |
| Mar '24 | $88M | -$16M | 37.5% | -1.3% | — | — | $29M |
| Dec '23 | $87M | -$25M | 35.5% | -7.6% | — | — | $46M |
| Sep '23 | $86M | -$16M | 36.6% | -1.1% | — | — | $51M |
| Jun '23 | $86M | -$17M | 37.8% | 0.9% | — | — | $72M |
| Mar '23 | $87M | -$14M | 38.3% | 2.2% | — | — | $36M |
| Dec '22 | $85M | -$19M | 33.4% | -5.5% | — | — | $54M |
| Sep '22 | $83M | -$20M | 38.7% | -10.0% | — | — | $40M |
| Jun '22 | $84M | -$18M | 37.3% | -7.1% | — | — | $43M |
| Mar '22 | $84M | -$23M | 36.5% | -15.1% | — | — | $66M |
| Dec '21 | $83M | -$19M | 35.1% | -9.2% | — | — | $60M |
| Sep '21 | $82M | -$40M | 37.5% | -34.9% | — | — | $30M |
| Jun '21 | $81M | -$14M | 36.5% | -2.6% | — | — | $47M |
Valuation over time
How the market has priced NHP against its own fundamentals since 2026-04 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-sales ratio has risen from 1.1× (Apr '26) to 1.2× (Jun '26).
P/S
Frequently asked questions
Is NHP growing its revenue and profit?
Over the past 5 years, National Healthcare Properties, Inc.'s revenue has declined 2.2% per year. These are computed facts, not advice.
How much debt does NHP have?
As of FY2025, National Healthcare Properties, Inc. reported — of total debt against $58M of cash; operating income covered interest expense 0.1×.
What is NHP's profit margin?
In FY2025, gross margin was 36.0%, operating margin 1.0%, and net margin -16.9%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.